Cargando…

Multicenter Clinical Cancer Research After COVID-19: A Perspective From NRG Oncology

Detalles Bibliográficos
Autores principales:	Gensheimer, Michael F., Yom, Sue S., Soto, Nancy, Dignam, James J., Le, Quynh-Thu, Machtay, Mitchell, Curran, Walter J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Inc. 2020
Materias:	The Conduct of Clinical Trials
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7462891/ https://www.ncbi.nlm.nih.gov/pubmed/32890539 http://dx.doi.org/10.1016/j.ijrobp.2020.06.056

Ejemplares similares

Clinical Research in the Time of COVID-19
por: Felix, Carol
Publicado: (2020)

Life After COVID-19 for Cancer Clinical Trials
por: Hall, Emma, et al.
Publicado: (2020)

Reduced-Dose Radiation Therapy for HPV-Associated Oropharyngeal Carcinoma (NRG Oncology HN002)
por: Yom, Sue S., et al.
Publicado: (2021)

The conductor and his score
por: Green, Elizabeth A. H.
Publicado: (1975)

Assessing the potential for prevention or earlier detection of on-site monitoring findings from randomised controlled trials: Further analyses of findings from the prospective TEMPER triggered monitoring study
por: Cragg, William J, et al.
Publicado: (2020)

Risk-adapted monitoring is not inferior to extensive on-site monitoring: Results of the ADAMON cluster-randomised study
por: Brosteanu, Oana, et al.
Publicado: (2017)

Impact of retrospective data verification to prepare the ICON6 trial for use in a marketing authorization application
por: Embleton-Thirsk, Andrew, et al.
Publicado: (2019)

Improving lung cancer screening rates among patients with head and neck cancer in a radiation oncology clinic
por: Soto, Lina, et al.
Publicado: (2022)

Child Welfare at Brussels
Publicado: (1921)

Comments on the Publication by Corkum et al on “Does 5 + 5 mm Equal Better Radiation Treatment Plans in Head and Neck Cancers?”
por: Grégoire, Vincent, et al.
Publicado: (2020)

NRG Oncology Survey on Practice and Technology Use in SRT and SBRT Delivery
por: Chetvertkov, Mikhail, et al.
Publicado: (2020)

Association of Radiotherapy Duration With Clinical Outcomes in Patients With Esophageal Cancer Treated in NRG Oncology Trials: A Secondary Analysis of NRG Oncology Randomized Clinical Trials
por: Hallemeier, Christopher L., et al.
Publicado: (2023)

Independently validated sex-specific nomograms for predicting survival in patients with newly diagnosed glioblastoma: NRG Oncology RTOG 0525 and 0825
por: Patil, Nirav, et al.
Publicado: (2021)

The ARRIVE guidelines 2.0: updated guidelines for reporting animal research
por: Percie du Sert, Nathalie, et al.
Publicado: (2020)

Impact of tumour histology on survival in advanced cervical carcinoma: an NRG Oncology/Gynaecologic Oncology Group Study
por: Seamon, Leigh G, et al.
Publicado: (2018)

Recruitment practices for U.S. minority and underserved populations in NRG oncology: Results of an online survey()
por: Cook, Elise D., et al.
Publicado: (2018)

NRG-1 talks back to neurons
por: LeBrasseur, Nicole
Publicado: (2003)

Return of individual genomic research results within the PRAEGNANT multicenter registry study
por: Huebner, Hanna, et al.
Publicado: (2022)

RADI-04. PRETREATMENT VOLUME OF MRI-DETERMINED WHITE MATTER INJURY (WMI) PREDICTS COGNITIVE DECLINE AFTER HIPPOCAMPAL AVOIDANT (HA) WBRT FOR BRAIN METASTASES: SECONDARY ANALYSIS OF NRG ONCOLOGY RTOG 0933
por: Bovi, Joseph, et al.
Publicado: (2019)

NRG-GU012: randomized phase II stereotactic ablative radiation therapy (SABR) for metastatic unresected renal cell carcinoma (RCC) receiving immunotherapy (SAMURAI)
por: McKay, Rana
Publicado: (2023)

Pretreatment Volume of MRI-Determined White Matter Injury Predicts Neurocognitive Decline After Hippocampal Avoidant Whole-Brain Radiation Therapy for Brain Metastases: Secondary Analysis of NRG Oncology Radiation Therapy Oncology Group 0933
por: Bovi, Joseph A., et al.
Publicado: (2019)

Adding Base-Excision Repair Inhibitor TRC102 to Standard Pemetrexed–Platinum–Radiation in Patients with Advanced Nonsquamous Non–Small Cell Lung Cancer: Results of a Phase I Trial
por: Biswas, Tithi, et al.
Publicado: (2022)

NRG Oncology Survey of Monte Carlo Dose Calculation Use in US Proton Therapy Centers
por: Lin, Liyong, et al.
Publicado: (2021)

Improving Risk Assessment for Metastatic Disease in Endometrioid Endometrial Cancer Patients Using Molecular and Clinical Features: An NRG Oncology/Gynecologic Oncology Group Study
por: Casablanca, Yovanni, et al.
Publicado: (2022)

NRG Oncology/NSABP B-47 menstrual history study: impact of adjuvant chemotherapy with and without trastuzumab
por: Ganz, Patricia A., et al.
Publicado: (2021)

Follow-Up with Exercise Test of Effort-Induced Ventricular Arrhythmias Linked to Ryanodine Receptor Type 2 Gene Mutations
por: Steriotis, Alexandros Klavdios, et al.
Publicado: (2012)

Noninvasive Cardiac Screening in Young Athletes With Ventricular Arrhythmias
por: Steriotis, Alexandros Klavdios, et al.
Publicado: (2013)

Evolutionary Action Score of TP53 Analysis in Pathologically High-Risk Human Papillomavirus-Negative Head and Neck Cancer From a Phase 2 Clinical Trial: NRG Oncology Radiation Therapy Oncology Group 0234
por: Michikawa, Chieko, et al.
Publicado: (2022)

Validation of the NSABP/NRG Oncology 8-Gene Trastuzumab-benefit Signature in Alliance/NCCTG N9831
por: Pogue-Geile, Katherine L, et al.
Publicado: (2020)

Effects of RET, NRG1 and NRG3 Polymorphisms in a Chinese Population with Hirschsprung Disease
por: Yang, Dehua, et al.
Publicado: (2017)

A multicenter trial evaluating retaspimycin HCL (IPI-504) plus trastuzumab in patients with advanced or metastatic HER2-positive breast cancer
por: Modi, Shanu, et al.
Publicado: (2013)

Sphincter preservation in patients with low rectal cancer: striking the right oncological balance
por: Luvisetto, Federico, et al.
Publicado: (2021)

Aligning Objectives and Assessment in Responsible Conduct of Research Instruction
por: Antes, Alison L., et al.
Publicado: (2014)

Smart Teaching Matters! Applying the Research on Learning to Teaching RCR
por: Nebeker, Camille
Publicado: (2014)

Final survival analysis of topotecan and paclitaxel for first-line treatment of advanced cervical cancer: An NRG oncology randomized study
por: Tewari, Krishnansu S., et al.
Publicado: (2023)

A Modest Proposal to Move RCR Education Out of the Classroom and into Research
por: Kalichman, Michael
Publicado: (2014)

NRG1 fusions in breast cancer
por: Howarth, Karen D., et al.
Publicado: (2021)

Effect of Remote Ischaemic Conditioning in Oncology Patients Undergoing Chemotherapy: Rationale and Design of the ERIC‐ONC Study—A Single‐Center, Blinded, Randomized Controlled Trial
por: Chung, Robin, et al.
Publicado: (2016)

New Therapy for Refractory Chronic Mechanical Low Back Pain—Restorative Neurostimulation to Activate the Lumbar Multifidus: One Year Results of a Prospective Multicenter Clinical Trial
por: Deckers, Kristiaan, et al.
Publicado: (2017)

Phase II evaluation of copanlisib, a selective inhibitor of Pi3kca, in patients with persistent or recurrent endometrial carcinoma harboring PIK3CA hotspot mutations: An NRG Oncology study (NRG-GY008)
por: Santin, Alessandro D., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_j71rbdrtfaa5eumta71k1k7brr